ARCHIVES

Interactive R01 Scores Vary widely, Result Of separate Review

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

UICC Receives 1300 Abstracts For Congress In Oslo, Norway.

February 22, 2002

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

Pas Available; Alternative Medicine

January 21, 1994

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011